A retrospective, single-center analysis of specialized palliative care services for patients with advanced small-cell lung cancer

Article indépendant

WACHTER, Claudia | HACKNER, Klaus | GROISSENBERGER, Iris | JUTZ, Franziska | TSCHURLOVICH, Lisa | LE, Nguyen-Son | KREYE, Gudrun

Timely integration of specialized palliative care (SPC) has been shown to improve cancer patients’ quality of life (QoL) and reduced the use of medical services. To evaluate the level of integration of SPC services for patients with advanced small-cell lung cancer (SCLC), we retrospectively analyzed medical records of patients from 2019 to 2021. Regarding the timing of referral to SPC services, we defined four cutoffs for early referral according to the current literature: (a) SPC provided = 60 days after diagnosis; (b) SPC provided = 60 days before death; (c) SPC provided = 30 days before death; and (d) SPC provided = 130 days before death. One hundred and forty-three patients (94.1%) were found to have locally advanced (stage III) or metastatic (stage IV) disease. Sixty-eight were not referred to SPC services (47.6%), whereas 75 patients received SPC (52.4%). We found a significantly higher number of referrals to SPC services for patients with higher ECOG (Eastern Cooperative Oncology Group) (i.e., ECOG = 2) (p = 0.010) and patients with stage IV disease (p = 0.001). The median overall survival (OS) for SCLC stage III/IV patients (n = 143) who did not receive SPC treatment was 17 months (95% CI 8.5–25.5), while those who did receive SPC treatment had a median OS of 8 months (95% CI 6.2–9.8) (p = 0.014). However, when we evaluated patients receiving SPC treatment in a timely manner before death as suggested by the different cutoffs indicated in the literature, they lived significantly longer when referred at a minimum of =60 or =130 days before death. Based on our findings, we suggest that patients with advanced SCLC should participate in a consultation with a SPC team in a timely manner to ensure a benefit of SPC for this patient group.

http://dx.doi.org/10.3390/cancers14204988

Voir la revue «Cancers, 14»

Autres numéros de la revue «Cancers»

Consulter en ligne

Suggestions

Du même auteur

A retrospective, single-center analysis of sp...

Article | WACHTER, Claudia | Cancers | n°20 | vol.14

Timely integration of specialized palliative care (SPC) has been shown to improve cancer patients’ quality of life (QoL) and reduced the use of medical services. To evaluate the level of integration of SPC services for patie...

A retrospective, single-center analysis of sp...

Article indépendant | WACHTER, Claudia | Cancers | n°20 | vol.14

Timely integration of specialized palliative care (SPC) has been shown to improve cancer patients’ quality of life (QoL) and reduced the use of medical services. To evaluate the level of integration of SPC services for patie...

Systemic anticancer treatment near the end of...

Article | GEYER, Teresa | Current treatment options in oncology

Systemic anticancer therapy (SACT) includes different treatment modalities that can be effective in treating cancer. However, in the case of disease progression, cancers might become incurable and SACT might reach its limits. In t...

De la même série

An evaluation of rare cancer policies in Euro...

Article indépendant | KOSTADINOV, Kostadin | Cancers | n°2 | vol.17

Rare cancers, defined as those with an annual incidence of fewer than six cases per 100,000 individuals, are associated with significant health inequalities. This study aimed to assess the knowledge, attitudes, and perceptions of ...

Association between Medicaid expansion and in...

Article indépendant | PATEL, Tej A. | Cancers | n°3 | vol.17

Background: Although the Patient Protection and Affordable Care Act (ACA) has been associated with increased Medicaid coverage among prostate cancer patients, the association between Medicaid expansion with risk group at diagnosis...

Assessment tools to examine illness understan...

Article indépendant | TU, Ashlyn | Cancers | n°3 | vol.17

The best tools to assess patient illness understanding are unclear. Here, we examined the assessment tools for illness understanding administered in randomized clinical trials (RCTs) involving patients with advanced cancer, how ac...

Go wish card game for meaningful conversation...

Article indépendant | SAKAMOTO RIBEIRO PAIVA, Bianca | Cancers | n°4 | vol.17

The Go Wish Card Game (GWCG) is emerging as a valuable tool for facilitating end-of-life (EoL) discussions, particularly in oncology care where patients face complex treatment decisions. This review investigates the GWCG's intende...

Predictors and drivers of end-of-life Medicar...

Article indépendant | BAIRD, Courtney E. | Cancers | n°6 | vol.17

Purpose: Medicare patients who die from cancer are responsible for about 30% of annual Medicare spending, most of which occurs during the last 30 days of life. Yet, there are significant and persisting knowledge gaps regarding whi...

Chargement des enrichissements...